Researchers found that when the drugs were used to treat dermatological conditions, the risk of acne was significantly higher than when they were used to treat other ailments.
Side effects of Xeljanz, Rinvoq, Olumiant and Other Janus Kinase (JAK) inhibitors linked to higher cancer risk than TNF inhibitors, like Humira and Enbrel
Drug companies spend billions of dollars on television commercials for drugs that are more expensive and less effective than other treatments, according to the findings
Regulators made the determination following recent studies linking Xeljanz side effects to adverse health risks.
Researchers said neither the side effects of Xeljanz, or similar drugs appear to increase the risk of venous thromboembolism-related injuries.
Following recent concerns about the risk of cancer, heart problems and blood clots from side effects of Xeljanz, new study finds an infection risk is yet another potential complication linked to the arthritis drug.
Xeljanz, Jakafi and other JAK inhibitors were linked to an increased risk of melanoma, squamous cell carcinoma and Merkel cell carcinoma
The Rinvoq lawsuit says AbbVie executives mislead investors by failing to disclose safety concerns affecting Xeljanz would also apply to Rinvoq.
The Xeljanz stroke lawsuit claims the drug's side effects caused a Kentucky woman to temporarily lose control of the right side of her body.
Pfizer allegedly knew about the blood clot risks with Xeljanz, but misled patients and the medical community in order to maximize profits.
